Cargando…

The protective efficacy and safety of bandage contact lenses in children aged 5 to 11 after frontalis muscle flap suspension for congenital blepharoptosis: A single-center randomized controlled trial

BACKGROUND: Postoperative complications, lagophthalmos and exposure keratopathy sometimes occur after surgery for congenital blepharoptosis. Bandage contact lenses (BCL) can help prevent some ocular surface disorders. The study aims to evaluate the efficacy and safety of BCL for protection of the oc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lin, Pi, Lianhong, Ke, Ning, Chen, Xinke, Liu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392512/
https://www.ncbi.nlm.nih.gov/pubmed/28885362
http://dx.doi.org/10.1097/MD.0000000000008003
_version_ 1783398489119522816
author Chen, Lin
Pi, Lianhong
Ke, Ning
Chen, Xinke
Liu, Qing
author_facet Chen, Lin
Pi, Lianhong
Ke, Ning
Chen, Xinke
Liu, Qing
author_sort Chen, Lin
collection PubMed
description BACKGROUND: Postoperative complications, lagophthalmos and exposure keratopathy sometimes occur after surgery for congenital blepharoptosis. Bandage contact lenses (BCL) can help prevent some ocular surface disorders. The study aims to evaluate the efficacy and safety of BCL for protection of the ocular surface in children aged 5 to 11 years after frontalis muscle flap suspension for congenital blepharoptosis. METHODS: We conducted a prospective randomized clinical study of 30 eyes of 30 patients with congenital blepharoptosis consecutively enrolled at the Ophthalmology Ward of the Children's Hospital of Chongqing Medical University, China from September 1, 2016, to February 30, 2017. After frontalis muscle flap suspension surgery, patients were randomly assigned to undergo BCL application (BCL group, 15 eyes) or no BCL application (control group, 15 eyes). All patients were treated with bramycin 0.3% and polyvinyl alcohol drops after surgery. The primary outcomes were dry eye assessed by tear film break time (TFBUT), fluoresce in corneal staining (FCS) on slit-lamp on days 1, 3, and 15 postoperatively, and lower tear meniscus height (LTMH) on optical coherence tomography on days 1 and 15 postoperatively. Secondary outcomes were pairwise correlation of TFBUT, FCS and LTMH. RESULTS: In the BCL group, abnormal TFBUT and FCS were only found in 2 patients (13.33%) on postoperative day 15. In the control group, the incidence of dry eye assessed by TFBUT was 67.00% (10/15 eyes) on day 1, 73.33% (11/15 eyes) on day 3, and 53.33% (8/15 eyes) on day 15 (P < .001). LTMH were significantly higher in the BCL group than the control group postoperatively (P < .001). Significant positive correlations were found between LTMH and TFBUT pre-operation and on days 1 and 15 post-operation. For LTMH and FCSS (R = −0.815, P < .001), and TFBUT and FCS (R = −0.837, P < .001), the Pearson coefficient was negative on postoperative day 1, but not correlated on day 15. CONCLUSIONS: Silicone hydrogel BCL were safe and efficacious for protective use in children after frontalis muscle flap suspension for congenital blepharoptosis.
format Online
Article
Text
id pubmed-6392512
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-63925122019-03-15 The protective efficacy and safety of bandage contact lenses in children aged 5 to 11 after frontalis muscle flap suspension for congenital blepharoptosis: A single-center randomized controlled trial Chen, Lin Pi, Lianhong Ke, Ning Chen, Xinke Liu, Qing Medicine (Baltimore) Research Article BACKGROUND: Postoperative complications, lagophthalmos and exposure keratopathy sometimes occur after surgery for congenital blepharoptosis. Bandage contact lenses (BCL) can help prevent some ocular surface disorders. The study aims to evaluate the efficacy and safety of BCL for protection of the ocular surface in children aged 5 to 11 years after frontalis muscle flap suspension for congenital blepharoptosis. METHODS: We conducted a prospective randomized clinical study of 30 eyes of 30 patients with congenital blepharoptosis consecutively enrolled at the Ophthalmology Ward of the Children's Hospital of Chongqing Medical University, China from September 1, 2016, to February 30, 2017. After frontalis muscle flap suspension surgery, patients were randomly assigned to undergo BCL application (BCL group, 15 eyes) or no BCL application (control group, 15 eyes). All patients were treated with bramycin 0.3% and polyvinyl alcohol drops after surgery. The primary outcomes were dry eye assessed by tear film break time (TFBUT), fluoresce in corneal staining (FCS) on slit-lamp on days 1, 3, and 15 postoperatively, and lower tear meniscus height (LTMH) on optical coherence tomography on days 1 and 15 postoperatively. Secondary outcomes were pairwise correlation of TFBUT, FCS and LTMH. RESULTS: In the BCL group, abnormal TFBUT and FCS were only found in 2 patients (13.33%) on postoperative day 15. In the control group, the incidence of dry eye assessed by TFBUT was 67.00% (10/15 eyes) on day 1, 73.33% (11/15 eyes) on day 3, and 53.33% (8/15 eyes) on day 15 (P < .001). LTMH were significantly higher in the BCL group than the control group postoperatively (P < .001). Significant positive correlations were found between LTMH and TFBUT pre-operation and on days 1 and 15 post-operation. For LTMH and FCSS (R = −0.815, P < .001), and TFBUT and FCS (R = −0.837, P < .001), the Pearson coefficient was negative on postoperative day 1, but not correlated on day 15. CONCLUSIONS: Silicone hydrogel BCL were safe and efficacious for protective use in children after frontalis muscle flap suspension for congenital blepharoptosis. Wolters Kluwer Health 2017-09-08 /pmc/articles/PMC6392512/ /pubmed/28885362 http://dx.doi.org/10.1097/MD.0000000000008003 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Chen, Lin
Pi, Lianhong
Ke, Ning
Chen, Xinke
Liu, Qing
The protective efficacy and safety of bandage contact lenses in children aged 5 to 11 after frontalis muscle flap suspension for congenital blepharoptosis: A single-center randomized controlled trial
title The protective efficacy and safety of bandage contact lenses in children aged 5 to 11 after frontalis muscle flap suspension for congenital blepharoptosis: A single-center randomized controlled trial
title_full The protective efficacy and safety of bandage contact lenses in children aged 5 to 11 after frontalis muscle flap suspension for congenital blepharoptosis: A single-center randomized controlled trial
title_fullStr The protective efficacy and safety of bandage contact lenses in children aged 5 to 11 after frontalis muscle flap suspension for congenital blepharoptosis: A single-center randomized controlled trial
title_full_unstemmed The protective efficacy and safety of bandage contact lenses in children aged 5 to 11 after frontalis muscle flap suspension for congenital blepharoptosis: A single-center randomized controlled trial
title_short The protective efficacy and safety of bandage contact lenses in children aged 5 to 11 after frontalis muscle flap suspension for congenital blepharoptosis: A single-center randomized controlled trial
title_sort protective efficacy and safety of bandage contact lenses in children aged 5 to 11 after frontalis muscle flap suspension for congenital blepharoptosis: a single-center randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392512/
https://www.ncbi.nlm.nih.gov/pubmed/28885362
http://dx.doi.org/10.1097/MD.0000000000008003
work_keys_str_mv AT chenlin theprotectiveefficacyandsafetyofbandagecontactlensesinchildrenaged5to11afterfrontalismuscleflapsuspensionforcongenitalblepharoptosisasinglecenterrandomizedcontrolledtrial
AT pilianhong theprotectiveefficacyandsafetyofbandagecontactlensesinchildrenaged5to11afterfrontalismuscleflapsuspensionforcongenitalblepharoptosisasinglecenterrandomizedcontrolledtrial
AT kening theprotectiveefficacyandsafetyofbandagecontactlensesinchildrenaged5to11afterfrontalismuscleflapsuspensionforcongenitalblepharoptosisasinglecenterrandomizedcontrolledtrial
AT chenxinke theprotectiveefficacyandsafetyofbandagecontactlensesinchildrenaged5to11afterfrontalismuscleflapsuspensionforcongenitalblepharoptosisasinglecenterrandomizedcontrolledtrial
AT liuqing theprotectiveefficacyandsafetyofbandagecontactlensesinchildrenaged5to11afterfrontalismuscleflapsuspensionforcongenitalblepharoptosisasinglecenterrandomizedcontrolledtrial
AT chenlin protectiveefficacyandsafetyofbandagecontactlensesinchildrenaged5to11afterfrontalismuscleflapsuspensionforcongenitalblepharoptosisasinglecenterrandomizedcontrolledtrial
AT pilianhong protectiveefficacyandsafetyofbandagecontactlensesinchildrenaged5to11afterfrontalismuscleflapsuspensionforcongenitalblepharoptosisasinglecenterrandomizedcontrolledtrial
AT kening protectiveefficacyandsafetyofbandagecontactlensesinchildrenaged5to11afterfrontalismuscleflapsuspensionforcongenitalblepharoptosisasinglecenterrandomizedcontrolledtrial
AT chenxinke protectiveefficacyandsafetyofbandagecontactlensesinchildrenaged5to11afterfrontalismuscleflapsuspensionforcongenitalblepharoptosisasinglecenterrandomizedcontrolledtrial
AT liuqing protectiveefficacyandsafetyofbandagecontactlensesinchildrenaged5to11afterfrontalismuscleflapsuspensionforcongenitalblepharoptosisasinglecenterrandomizedcontrolledtrial